Metabolomic assessment of mechanisms underlying anti-renal fibrosis properties of petroleum ether extract from Amygdalus mongolica

Metabolomic assessment of mechanisms underlying anti-renal fibrosis properties of petroleum ether extract from Amygdalus mongolica

Context The petroleum ether extract (PET) of Amygdalus mongolica (Maxim.) Ricker (Rosaceae) has an ameliorative effect on renal fibrosis (RF). Objective To evaluate the antifibrotic effects of A. mongolica seeds PET on RF by serum metabolomics, biochemical and histopathological analyses. Materials a...

書誌詳細
主要な著者:	Chen Gao, Wan-fu Bai, Hong-bing Zhou, Hai-mei Hao, Ying-chun Bai, Quan-li Liu, Hong Chang, Song-li Shi
フォーマット:	論文
言語:	English
出版事項:	Taylor & Francis Group 2021-01-01
シリーズ:	Pharmaceutical Biology
主題:	traditional chinese medicine renal fibrosis biomarkers metabolic pathway mechanism research
オンライン･アクセス:	http://dx.doi.org/10.1080/13880209.2021.1920619

類似資料

Metabolomics reveal the mechanism for anti-renal fibrosis effects of an n-butanol extract from Amygdalus mongolica
著者:: Gao Chen, 等
出版事項: (2022-09-01)

Study on the mechanism of Amygdalus mongolica oil anti-renal fibrosis based on metabolomics and transcriptomics
著者:: Haimei Hao, 等
出版事項: (2022-12-01)

Study on miRNA expression and regulatory network of Amygdalus mongolica oil and amygdalin in the treatment of pulmonary fibrosis
著者:: Jiaxing Gao, 等
出版事項: (2024-06-01)

Amygdalin isolated from Amygdalus mongolica protects against hepatic fibrosis in rats
著者:: Wang Jia, 等
出版事項: (2021-09-01)

Metabolomics reveals the renoprotective effect of n-butanol extract and amygdalin extract from Amygdalus mongolica in rats with renal fibrosis
著者:: Wanfu Bai, 等
出版事項: (2021-01-01)

The intervention effect of Amygdalus mongolica oil on the metabolomics and intestinal flora in pulmonary fibrosis
著者:: Qian Li, 等
出版事項: (2022-11-01)

Effects of N-butanol extract of Amygdalus mongolica on rats with bleomycin‐induced pulmonary fibrosis based on metabolomics
著者:: Chen Gao, 等
出版事項: (2023-11-01)

Assessment of the renal function and fibrosis indexes of conventional western medicine with Chinese medicine for dredging collaterals on treating renal fibrosis: A systematic review and meta-analysis
著者:: Guo Yingbo, 等
出版事項: (2024-07-01)

Advances in the study of key cells and signaling pathways in renal fibrosis and the interventional role of Chinese medicines
著者:: Lijuan Liang, 等
出版事項: (2024-12-01)

Natural products: potential drugs for the treatment of renal fibrosis
著者:: Zijun Zhou, 等
出版事項: (2022-08-01)

Fu-Fang-Jin-Qian-Cao herbal granules protect against the calcium oxalate-induced renal EMT by inhibiting the TGF-β/smad pathway
著者:: Wen-Rui Liu, 等
出版事項: (2020-01-01)

Impact of baicalin and components of Scutellaria baicalensis on renal fibrosis of diabetic kidney disease
著者:: Jiarui Li, 等
出版事項: (2024-12-01)

Metabolic reprogramming and renal fibrosis: what role might Chinese medicine play?
著者:: Weili Wang, 等
出版事項: (2024-10-01)

Yiqi Juanshen decoction alleviates renal interstitial fibrosis by targeting the LOXL2/PI3K/AKT pathway to suppress EMT and inflammation
著者:: Kaiyue Tan, 等
出版事項: (2025-02-01)

Stem cells in the treatment of renal fibrosis: a review of preclinical and clinical studies of renal fibrosis pathogenesis
著者:: Yiping Liu, 等
出版事項: (2021-06-01)

Targeting the Wnt/β-Catenin Signaling Pathway as a Potential Therapeutic Strategy in Renal Tubulointerstitial Fibrosis
著者:: Shan-Shan Li, 等
出版事項: (2021-08-01)

Network pharmacology combined with molecular docking and experimental validation to reveal the pharmacological mechanism of naringin against renal fibrosis
著者:: Zhong Yanan, 等
出版事項: (2023-06-01)

Application of Histone Deacetylase Inhibitors in Renal Interstitial Fibrosis
著者:: Ling Nie, 等
出版事項: (2020-03-01)

Deciphering the Pharmacological Mechanisms of Taohe-Chengqi Decoction Extract Against Renal Fibrosis Through Integrating Network Pharmacology and Experimental Validation In Vitro and In Vivo
著者:: Shanshan Zhou, 等
出版事項: (2020-04-01)

Feifukang ameliorates pulmonary fibrosis by inhibiting JAK-STAT signaling pathway
著者:: Hongbo Li, 等
出版事項: (2018-08-01)

Tongluo Yishen Decoction Ameliorates Renal Fibrosis via NLRP3-Mediated Pyroptosis In Vivo and In Vitro
著者:: Qi Jia, 等
出版事項: (2022-07-01)

Drugs for treating myocardial fibrosis
著者:: Zhanhong Ren, 等
出版事項: (2023-09-01)

Multi-target regulatory effects of rhaponticin in a rat model of hepatic fibrosis revealed by non-targeted metabolomics
著者:: Min Yang, 等
出版事項: (2025-01-01)

A metabolomic approach to elucidate the inhibitory effects of baicalin in pulmonary fibrosis
著者:: Hong Chang, 等
出版事項: (2021-01-01)

Tetramethylpyrazine: An Active Ingredient of Chinese Herbal Medicine With Therapeutic Potential in Acute Kidney Injury and Renal Fibrosis
著者:: Jun Li, 等
出版事項: (2022-01-01)

Potential Therapeutic Strategies for Renal Fibrosis: Cordyceps and Related Products
著者:: Wei Tan, 等
出版事項: (2022-07-01)

Signaling Pathways Involved in Diabetic Renal Fibrosis
著者:: Yuqing Zhang, 等
出版事項: (2021-07-01)

Autophagy in renal fibrosis: Protection or promotion?
著者:: Rong Dai, 等
出版事項: (2022-08-01)

Cell–Matrix Interactions in Renal Fibrosis
著者:: Kristin P. Kim, 等
出版事項: (2022-12-01)

The role of lncRNA and miRNA in the pathogenesis of renal fibrosis
著者:: Liang CHANG, 等
出版事項: (2023-04-01)

Phylogeography of Amygdalus mongolica in relation to Quaternary climatic aridification and oscillations in northwestern China
著者:: Lin Zhang, 等
出版事項: (2022-04-01)

Total Flavonoids from Leaves of Carya Cathayensis Ameliorate Renal Fibrosis via the miR-21/Smad7 Signaling Pathway
著者:: Xiaoli Wu, 等
出版事項: (2018-09-01)

Dissecting Efficacy and Metabolic Characteristic Mechanism of Taxifolin on Renal Fibrosis by Multivariate Approach and Ultra-Performance Liquid Chromatography Coupled With Mass Spectrometry-Based Metabolomics Strategy
著者:: Lei Ren, 等
出版事項: (2021-01-01)

Dapagliflozin inhibits ferroptosis and ameliorates renal fibrosis in diabetic C57BL/6J mice
著者:: Zhen Zhang, 等
出版事項: (2025-02-01)

Naringin ameliorates experimental diabetic renal fibrosis by inhibiting the ERK1/2 and JNK MAPK signaling pathways
著者:: Yan Yang, 等
出版事項: (2018-11-01)

Research status and hotspots of traditional Chinese medicine in treatment of pulmonary fibrosis: based on bibliometric analysis
著者:: MIN Yi
出版事項: (2023-10-01)

Renal Fibrosis Is Significantly Attenuated Following Targeted Disruption of Cd40 in Experimental Renal Ischemia
著者:: Shungang Zhang, 等
出版事項: (2020-04-01)

The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway
著者:: Yadong Fu, 等
出版事項: (2021-09-01)

Integrated serum metabolomics and network pharmacology reveal molecular mechanism of Qixue Huazheng formula on peritoneal fibrosis
著者:: Xiaohui Meng, 等
出版事項: (2025-01-01)

Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy
著者:: Shengju Wang, 等
出版事項: (2023-07-01)